{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:47:19Z","timestamp":1778042839870,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10147-021-01994-w","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T21:02:51Z","timestamp":1626901371000},"page":"2053-2064","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV\/HCV-related hepatocellular carcinoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Jia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guixia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"1994_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A (2019) Hepatocellular Carcinoma. N Engl J Med 380:1450\u20131462","journal-title":"N Engl J Med"},{"key":"1994_CR2","first-page":"133","volume":"43","author":"A Budny","year":"2017","unstructured":"Budny A, Koz\u0142owski P, Kami\u0144ska M et al (2017) Epidemiology and risk factors of hepatocellular carcinoma. Pol Merkur Lekarski 43:133\u2013139","journal-title":"Pol Merkur Lekarski"},{"key":"1994_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.lfs.2018.04.051","volume":"205","author":"M Xie","year":"2018","unstructured":"Xie M, Yang Z, Liu Y et al (2018) The role of HBV-induced autophagy in HBV replication and HBV related-HCC. Life Sci 205:107\u2013112","journal-title":"Life Sci"},{"key":"1994_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","volume":"10","author":"B Hajarizadeh","year":"2013","unstructured":"Hajarizadeh B, Grebely J, Dore GJ (2013) Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 10:553\u2013562","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1994_CR5","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2217\/epi-2016-0027","volume":"8","author":"SM Lee","year":"2016","unstructured":"Lee SM, Kim-Ha J, Choi WY et al (2016) Interplay of genetic and epigenetic alterations in hepatocellular carcinoma. Epigenomics 8:993\u20131005","journal-title":"Epigenomics"},{"key":"1994_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2014.01.011","volume":"28","author":"F Zeng","year":"2014","unstructured":"Zeng F, Harris RC (2014) Epidermal growth factor, from gene organization to bedside. Semin Cell Dev Biol 28:2\u201311","journal-title":"Semin Cell Dev Biol"},{"key":"1994_CR7","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/hep.22857","volume":"49","author":"ED Brennd\u00f6rfer","year":"2009","unstructured":"Brennd\u00f6rfer ED, Karthe J, Frelin L et al (2009) Nonstructural 3\/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase. Hepatology 49:1810\u20131820","journal-title":"Hepatology"},{"key":"1994_CR8","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1073\/pnas.1811064116","volume":"116","author":"M Iwamoto","year":"2019","unstructured":"Iwamoto M, Saso W, Sugiyama R et al (2019) Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization. Proc Natl Acad Sci USA 116:8487\u20138492","journal-title":"Proc Natl Acad Sci USA"},{"key":"1994_CR9","first-page":"100763","volume":"22","author":"CJ Gan","year":"2020","unstructured":"Gan CJ, Li WF, Li CN et al (2020) EGF receptor inhibitors comprehensively suppress hepatitis B virus by downregulation of STAT3 phosphorylation. Biochem Biophys Rep 22:100763","journal-title":"Biochem Biophys Rep"},{"key":"1994_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1177\/002215540004800610","volume":"48","author":"LG K\u00f6m\u00fcves","year":"2000","unstructured":"K\u00f6m\u00fcves LG, Feren A, Jones AL et al (2000) Expression of epidermal growth factor and its receptor in cirrhotic liver disease. J Histochem Cytochem 48:821\u2013830","journal-title":"J Histochem Cytochem"},{"key":"1994_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/labinvest.2010.161","volume":"91","author":"N Yoneda","year":"2011","unstructured":"Yoneda N, Sato Y, Kitao A et al (2011) Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma. Lab Invest 91:262\u2013272","journal-title":"Lab Invest"},{"issue":"Suppl 3","key":"1994_CR12","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/cogs.12580","volume":"42","author":"BM Lake","year":"2018","unstructured":"Lake BM, Lawrence ND, Tenenbaum JB (2018) The emergence of organizing structure in conceptual representation. Cogn Sci 42(Suppl 3):809\u2013832","journal-title":"Cogn Sci"},{"key":"1994_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(02)07600-6","volume":"359","author":"M Shahbazi","year":"2002","unstructured":"Shahbazi M, Pravica V, Nasreen N et al (2002) Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359:397\u2013401","journal-title":"Lancet"},{"key":"1994_CR14","first-page":"845","volume":"63","author":"S Zhang","year":"2017","unstructured":"Zhang S, Qiao K, Trieu C et al (2017) Genetic polymorphism of epidermal growth factor rs4444903 influences susceptibility to HCV-related liver cirrhosis and hepatocellular carcinoma in a chinese han population. Clin Lab 63:845\u2013850","journal-title":"Clin Lab"},{"key":"1994_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-230X-13-32","volume":"13","author":"JM Yuan","year":"2013","unstructured":"Yuan JM, Fan Y, Ognjanovic S et al (2013) Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies. BMC Gastroenterol 13:32","journal-title":"BMC Gastroenterol"},{"key":"1994_CR16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1089\/gtmb.2013.0031","volume":"17","author":"J Wu","year":"2013","unstructured":"Wu J, Zhang W, Xu A et al (2013) Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China. Genet Test Mol Biomarkers 17:595\u2013600","journal-title":"Genet Test Mol Biomarkers"},{"key":"1994_CR17","unstructured":"Wang H (2009) Epidemal growth factor gene polymorphisms associated with susceptibility to hepatocellular carcinoma. Guangxi Medical University."},{"key":"1994_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/jama.2007.65","volume":"299","author":"KK Tanabe","year":"2008","unstructured":"Tanabe KK, Lemoine A, Finkelstein DM et al (2008) Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA 299:53\u201360","journal-title":"JAMA"},{"key":"1994_CR19","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2147\/OTT.S53625","volume":"6","author":"M Suenaga","year":"2013","unstructured":"Suenaga M, Yamada S, Fujii T et al (2013) A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients. Onco Targets Ther 6:1805\u20131812","journal-title":"Onco Targets Ther"},{"key":"1994_CR20","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.7314\/APJCP.2012.13.12.6217","volume":"13","author":"HZ Shi","year":"2012","unstructured":"Shi HZ, Ren P, Lu QJ et al (2012) Association between EGF, TGF-\u03b21 and TNF-\u03b1 gene polymorphisms and hepatocellular carcinoma. Asian Pac J Cancer Prev 13:6217\u20136220","journal-title":"Asian Pac J Cancer Prev"},{"key":"1994_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/00313020903071603","volume":"41","author":"P Qi","year":"2009","unstructured":"Qi P, Wang H, Chen YM et al (2009) No association of EGF 5\u2019UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. Pathology 41:555\u2013560","journal-title":"Pathology"},{"key":"1994_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1478-3231.2009.02134.x","volume":"30","author":"Y Li","year":"2010","unstructured":"Li Y, Xie Q, Lu F et al (2010) Association between epidermal growth factor 61A\/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients. Liver Int 30:112\u2013118","journal-title":"Liver Int"},{"key":"1994_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ebiom.2016.11.031","volume":"15","author":"CF Huang","year":"2017","unstructured":"Huang CF, Huang CY, Yeh ML et al (2017) Genetics variants and serum levels of mhc class I chain-related A in predicting hepatocellular carcinoma development in chronic hepatitis c patients post antiviral treatment. EBioMedicine 15:81\u201389","journal-title":"EBioMedicine"},{"key":"1994_CR24","first-page":"284","volume":"10","author":"M Gholizadeh","year":"2017","unstructured":"Gholizadeh M, Khosravi A, Torabian P et al (2017) Association of the epidermal growth factor gene +61A>G polymorphism with hepatocellular carcinoma in an Iranian population. Gastroenterol Hepatol Bed Bench 10:284\u2013288","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"1994_CR25","doi-asserted-by":"publisher","first-page":"S261","DOI":"10.1016\/S0168-8278(13)60642-X","volume":"58","author":"M El-Bendary","year":"2013","unstructured":"El-Bendary M, Neamatallah M, El-Maksoud MA et al (2013) 640 epidemal growth factor genetic polymorphism predicts risk of hepatocellular carcinoma in egyptian patients with HCV (genotype 4)-related cirrhosis. J Hepatol 58:S261\u2013S261","journal-title":"J Hepatol"},{"key":"1994_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/gtmb.2010.0208","volume":"15","author":"K Chen","year":"2011","unstructured":"Chen K, Wei Y, Yang H et al (2011) Epidermal growth factor +61 G\/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population. Genet Test Mol Biomarkers 15:251\u2013255","journal-title":"Genet Test Mol Biomarkers"},{"key":"1994_CR27","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.31557\/APJCP.2020.21.7.2047","volume":"21","author":"I Baghdadi","year":"2020","unstructured":"Baghdadi I, Abu Ella K, El Shaaraway A et al (2020) Genetic polymorphism of epidermal growth factor gene as a predictor of hepatocellular carcinoma in hepatitis C cirrhotic patients. Asian Pac J Cancer Prev 21:2047\u20132053","journal-title":"Asian Pac J Cancer Prev"},{"key":"1994_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cyto.2011.10.018","volume":"57","author":"E Falleti","year":"2012","unstructured":"Falleti E, Cmet S, Fabris C et al (2012) Association between the epidermal growth factor rs4444903 G\/G genotype and advanced fibrosis at a young age in chronic hepatitis C. Cytokine 57:68\u201373","journal-title":"Cytokine"},{"key":"1994_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2249.2011.04497.x","volume":"167","author":"S Cmet","year":"2012","unstructured":"Cmet S, Fabris C, Fattovich G et al (2012) Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection. Clin Exp Immunol 167:296\u2013302","journal-title":"Clin Exp Immunol"},{"key":"1994_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1053\/j.gastro.2011.03.045","volume":"141","author":"BK Abu Dayyeh","year":"2011","unstructured":"Abu Dayyeh BK, Yang M, Fuchs BC et al (2011) A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology 141:141\u2013149","journal-title":"Gastroenterology"},{"key":"1994_CR31","first-page":"458","volume":"24","author":"E Abbas","year":"2012","unstructured":"Abbas E, Shaker O, Abd El Aziz G et al (2012) Epidermal growth factor gene polymorphism 61A\/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study. Eur J Gastroenterol Hepatol 24:458\u2013463","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1994_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603\u2013605","journal-title":"Eur J Epidemiol"},{"key":"1994_CR33","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"1994_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"1994_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/jcmm.12153","volume":"18","author":"P Huang","year":"2014","unstructured":"Huang P, Xu X, Wang L et al (2014) The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment. J Cell Mol Med 18:218\u2013230","journal-title":"J Cell Mol Med"},{"key":"1994_CR36","first-page":"765","volume":"10","author":"RR T\u00f6njes","year":"1995","unstructured":"T\u00f6njes RR, L\u00f6hler J, O\u2019Sullivan JF et al (1995) Autocrine mitogen IgEGF cooperates with c-myc or with the Hcs locus during hepatocarcinogenesis in transgenic mice. Oncogene 10:765\u2013768","journal-title":"Oncogene"},{"key":"1994_CR37","first-page":"733","volume":"33","author":"K Okamoto","year":"2008","unstructured":"Okamoto K, Neureiter D, Alinger B et al (2008) The dual EGF\/VEGF receptor tyrosine kinase inhibitor AEE788 inhibits growth of human hepatocellular carcinoma xenografts in nude mice. Int J Oncol 33:733\u2013742","journal-title":"Int J Oncol"},{"key":"1994_CR38","doi-asserted-by":"publisher","first-page":"e14007","DOI":"10.1097\/MD.0000000000014007","volume":"98","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Chen Z, Jiang H et al (2019) The genetic association between EGF A61G polymorphism (rs4444903) and risk of colorectal cancer: An update meta-analysis and trial sequential analysis. Medicine (Baltimore) 98:e14007","journal-title":"Medicine (Baltimore)"},{"key":"1994_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.gene.2013.01.057","volume":"519","author":"Y Piao","year":"2013","unstructured":"Piao Y, Liu Z, Ding Z et al (2013) EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis. Gene 519:26\u201333","journal-title":"Gene"},{"key":"1994_CR40","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s11033-019-04702-0","volume":"46","author":"AC Laus","year":"2019","unstructured":"Laus AC, de Paula FE, de Lima MA et al (2019) EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population. Mol Biol Rep 46:2417\u20132425","journal-title":"Mol Biol Rep"},{"key":"1994_CR41","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s13277-013-0730-2","volume":"34","author":"M Hu","year":"2013","unstructured":"Hu M, Shi H, Xu Z et al (2013) Association between epidermal growth factor gene rs4444903 polymorphism and risk of glioma. Tumour Biol 34:1879\u20131885","journal-title":"Tumour Biol"},{"key":"1994_CR42","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1089\/gtmb.2012.0050","volume":"16","author":"Z Yang","year":"2012","unstructured":"Yang Z, Wu Q, Shi Y et al (2012) Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis. Genet Test Mol Biomarkers 16:1086\u20131091","journal-title":"Genet Test Mol Biomarkers"},{"key":"1994_CR43","doi-asserted-by":"publisher","first-page":"e32159","DOI":"10.1371\/journal.pone.0032159","volume":"7","author":"JH Zhong","year":"2012","unstructured":"Zhong JH, You XM, Gong WF et al (2012) Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis. PLoS ONE 7:e32159","journal-title":"PLoS ONE"},{"key":"1994_CR44","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.7314\/APJCP.2015.16.7.3009","volume":"16","author":"S Sun","year":"2015","unstructured":"Sun S, Jin GJ, Zhao Y et al (2015) Association between the epidermal growth factor 61*A\/G polymorphism and hepatocellular carcinoma risk: a meta-analysis. Asian Pac J Cancer Prev 16:3009\u20133014","journal-title":"Asian Pac J Cancer Prev"},{"key":"1994_CR45","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.3892\/ol.2015.3723","volume":"10","author":"XF Shen","year":"2015","unstructured":"Shen XF, Zeng XT, Jian ZY et al (2015) Quantitative assessment of the effect of epidermal growth factor 61A\/G polymorphism on the risk of hepatocellular carcinoma. Oncol Lett 10:3199\u20133205","journal-title":"Oncol Lett"},{"key":"1994_CR46","doi-asserted-by":"publisher","first-page":"8066","DOI":"10.4238\/2014.October.7.1","volume":"13","author":"YL Li","year":"2014","unstructured":"Li YL, Tian Z, Zhao L et al (2014) Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression. Genet Mol Res 13:8066\u20138079","journal-title":"Genet Mol Res"},{"key":"1994_CR47","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12885-015-1318-6","volume":"15","author":"G Jiang","year":"2015","unstructured":"Jiang G, Yu K, Shao L et al (2015) Association between epidermal growth factor gene +61A\/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies. BMC Cancer 15:314","journal-title":"BMC Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-021-01994-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-021-01994-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-021-01994-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T17:23:22Z","timestamp":1634491402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-021-01994-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1994"],"URL":"https:\/\/doi.org\/10.1007\/s10147-021-01994-w","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"assertion":[{"value":"4 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}